HomeComparePHOJY vs MRK

PHOJY vs MRK: Dividend Comparison 2026

PHOJY yields 9.05% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PHOJY wins by $227053.59M in total portfolio value
10 years
PHOJY
PHOJY
● Live price
9.05%
Share price
$22.09
Annual div
$2.00
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$227053.65M
Annual income
$222,336,151,974.69
Full PHOJY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — PHOJY vs MRK

📍 PHOJY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPHOJYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PHOJY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PHOJY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PHOJY
Annual income on $10K today (after 15% tax)
$769.58/yr
After 10yr DRIP, annual income (after tax)
$188,985,729,178.49/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, PHOJY beats the other by $188,985,720,850.08/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PHOJY + MRK for your $10,000?

PHOJY: 50%MRK: 50%
100% MRK50/50100% PHOJY
Portfolio after 10yr
$113526.85M
Annual income
$111,168,080,886.42/yr
Blended yield
97.92%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PHOJY
No analyst data
Altman Z
4.9
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PHOJY buys
0
MRK buys
0
No recent congressional trades found for PHOJY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPHOJYMRK
Forward yield9.05%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$227053.65M$56.8K
Annual income after 10y$222,336,151,974.69$9,798.13
Total dividends collected$226733.20M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PHOJY vs MRK ($10,000, DRIP)

YearPHOJY PortfolioPHOJY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,511$1,810.78$11,206$366.19+$1.3KPHOJY
2$17,621$4,234.45$12,650$502.35+$5.0KPHOJY
3$30,002$11,147.79$14,407$694.19+$15.6KPHOJY
4$67,580$35,477.96$16,585$967.82+$51.0KPHOJY
5$221,684$149,372.85$19,342$1,363.89+$202.3KPHOJY
6$1,153,067$915,864.84$22,913$1,947.19+$1.13MPHOJY
7$10,138,043$8,904,261.91$27,662$2,823.89+$10.11MPHOJY
8$157,181,254$146,333,547.66$34,159$4,173.35+$157.15MPHOJY
9$4,408,875,972$4,240,692,030.29$43,337$6,308.80+$4408.83MPHOJY
10$227,053,649,265$222,336,151,974.69$56,776$9,798.13+$227053.59MPHOJY

PHOJY vs MRK: Complete Analysis 2026

PHOJYStock

Public Joint-Stock Company PhosAgro, together with its subsidiaries, engages in the production and distribution of apatite concentrate and mineral fertilizers in Russia and internationally. It operates in two segments, Phosphate-Based Products and Nitrogen-Based Products. The Phosphate-Based Products segment produces and distributes ammophos, diammoniumphosphate, sodium tripolyphosphate, and other phosphate based and complex fertilizers; and apatite concentrate extracted from the apatite-nepheline ore. The Nitrogen-Based Products segment is involved in the production and distribution of ammonia, ammonium nitrate, and urea. It also offers feed phosphates; phosphate rock; and industrial products, such as syenite alkali aluminum concentrate, titanomagnetite concentrate, nepheline concentrate, aegirine concentrate, oleum, sulphuric acid, sodiumsilicofluoride, aluminum fluoride, nitric acid, and ammonia solution. Public Joint-Stock Company PhosAgro was incorporated in 2001 and is headquartered in Moscow, the Russian Federation.

Full PHOJY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PHOJY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PHOJY vs SCHDPHOJY vs JEPIPHOJY vs OPHOJY vs KOPHOJY vs MAINPHOJY vs JNJPHOJY vs ABBVPHOJY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.